Breaking News

Tweet TWEET

The Alliance for Regenerative Medicine Holds Third Annual Stem Cell Meeting on the Mesa Regen Med Partnering Forum

The Alliance for Regenerative Medicine Holds Third Annual Stem Cell Meeting on 
the Mesa Regen Med Partnering Forum 
Meeting Will Take Place October 14 and 15 in La Jolla, California 
WASHINGTON, DC -- (Marketwired) -- 07/16/13 --  The Alliance for
Regenerative Medicine (ARM), the international organization
representing the interests of the regenerative medicine community,
today announced that the third annual Regen Med Partnering Forum will
take place October 14 and 15, 2013 as part of the Stem Cell Meeting
on the Mesa. This forum is the only partnering meeting organized
specifically for the regenerative medicine field, and has become the
premier gathering place for more than 300 senior level executives
seeking opportunities to collaborate and learn more about recent
advances in the space. Life Technologies Corporation (NASDAQ: LIFE)
is the meeting's founding and platinum-level sponsor. 
The Regen Med Partnering Forum will take place at the Estancia La
Jolla Hotel & Spa, La Jolla, California. The Stem Cell Meeting on the
Mesa's eighth Annual Scientific Symposium will immediately follow the
Regen Med Partnering Forum on October 16, 2013 at the Salk Institute
for Biological Studies. The Scientific Symposium, organized by the
Sanford Consortium for Regenerative Medicine, is attended by leading
scientists and researchers in the field, as well as participants from
the business and patient advocacy communities. Combined, these
meetings will attract over 800 attendees from around the globe,
highlighting the promise and progress of this rapidly evolving,
interdisciplinary field.  
"Stem Cell Meeting on the Mesa is the premier annual meeting for
anyone involved in regenerative medicine, cell therapy and stem cell
research," said Geoff MacKay, President & Chief Executive Officer of
Organogenesis Inc. and Chairman of ARM. "The quality of speakers --
both industry and academic -- combined with high-level partnering
opportunities, makes attending this meeting every year a top
priority."  
In addition to presentations by 40 cutting-edge companies seeking
partners and investors, the Regen Med Partnering Forum will include
interactive panels addressing critical commercial, scientific,
regulatory and reimbursement issues. One-on-one meetings will also be
scheduled with a state-of-the-art partnering system to connect
participants. The Regen Med Partnering Forum was developed by the
Alliance for Regenerative Medicine (ARM) and the California Institute
for Regenerative Medicine (CIRM) in 2011 and has grown 35% over the
past three years.  
"Life Technologies has sponsored this meeting since its inception in
2006, and helped it grow into a leading, annual conference for the
regenerative medicine community," said Alaine Maxwell, Associate
Director, Americas Marketing, Stem Cells and Translational Research,
Life Technologies. "Whether your goal is to gain exposure to
researchers or put your name out in front of C-level executives,
attending this meeting has incredible value." 
To learn more or to register for the 2013 Stem Cell Meeting on the
Mesa please visit www.stemcellmeetingonthemesa.com. Registration is
complimentary for investors and credentialed members of the media. 
About The Alliance for Regenerative Medicine
 The Alliance for
Regenerative Medicine (ARM) is a Washington, DC-based
multi-stakeholder advocacy organization that promotes legislative,
regulatory and reimbursement initiatives necessary to facilitate
access to life-giving advances in regenerative medicine. ARM also
works to increase public understanding of the field and its potential
to transform human healthcare, providing business development and
investor outreach services to support the growth of its member
companies and research organizations. Prior to the formation of ARM
in 2009, there was no advocacy organization operating in Washington,
DC to specifically represent the interests of the companies, research
institutions, investors and patient groups that comprise the entire
regenerative medicine community. Today ARM has more than 140 members
and is the leading global advocacy organization in this field. To
learn more about ARM or to become a member, visit www.alliancerm.org. 
About Life Technologies 
 Life Technologies Corporation (NASDAQ:
LIFE) is a global biotechnology company that is committed to
providing the most innovative products and services to leading
customers in the fields of scientific research, genetic analysis and
applied sciences. With a presence in more than 180 countries, the
company's portfolio of 50,000 end-to-end solutions is secured by more
than 5,000 patents and licenses that span the entire biological
spectrum -- scientific exploration, molecular diagnostics, 21st
century forensics, regenerative medicine and agricultural research.
Life Technologies has approximately 10,000 employees and had sales of
$3.8 billion in 2012. 
Life Technologies' Safe Harbor Statement 
 This press release
includes forward-looking statements about our anticipated results
that involve risks and uncertainties. Some of the information
contained in this press release, including, but not limited to,
statements as to industry trends and Life Technologies' plans,
objectives, expectations and strategy for its business, contains
forward-looking statements that are subject to risks and
uncertainties that could cause actual results or events to differ
materially from those expressed or implied by such forward-looking
statements. Any statements that are not statements of historical fact
are forward-looking statements. When used, the words "believe,"
"plan," "intend," "anticipate," "target," "estimate," "expect" and
the like, and/or future tense or conditional constructions ("will,"
"may," "could," "should," etc.), or similar expressions, identify
certain of these forward-looking statements. Important factors which
could cause actual results to differ materially from those in the
forward-looking statements are detailed in filings made by Life
Technologies with the Securities and Exchange Commission. Life
Technologies undertakes no obligation to update or revise any such
forward-looking statements to reflect subsequent events or
circumstances.  
Investor Contact:
Laura Parsons
Alliance for Regenerative Medicine
Phone: 208-841-4334 
Media Contact:
Michelle Linn
Linnden Communications
Phone: 508-362-3087